Pediatric Critical Care Transfusion and Anemia Expertise Initiative
儿科重症监护输血和贫血专业知识计划
基本信息
- 批准号:9126170
- 负责人:
- 金额:$ 0.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-01 至 2018-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcute Lung InjuryAgreementAmericanAnemiaAnthropologyAreaBloodBlood BanksCaringChildChild CareChildhoodClinicalClinical ResearchCollaborationsCommunitiesConsensusCritical CareCritical IllnessCritically ill childrenDataDecision TreesEngineeringEnsureEnvironmentErythrocyte TransfusionErythrocytesHemoglobinHemorrhageHemostatic functionHumanInternationalJournalsLength of StayLettersLibrary ScienceMedicalMedicineMethodologyMethodsMorbidity - disease ratePacked Red Blood Cell TransfusionPatient-Focused OutcomesPediatric Intensive Care UnitsPeer ReviewPopulationPositioning AttributeProcessPublishingRecommendationResearchResearch PersonnelRiskSafetySepsisSeriesSocietiesStructureSystemTransfusionWritingevidence baseimplementation scienceimprovedimproved outcomelead seriesmeetingsmortalitymultidisciplinarynovelpublic health relevancesymposiumsystematic reviewuptake
项目摘要
DESCRIPTION (provided by applicant): Nearly half of critically ill children with a pediatric intensive care unit (PICU) length of stay >48hrs will receive a transfusion of packed red blood cells (pRBC). Despite evidence that a lower hemoglobin threshold for pRBC transfusion in the PICU is safe, multiple studies have shown that the threshold in practice is much higher, exposing children to the significant morbidity and mortality associated with pRBC. Therefore there is increased need for evidence- based blood management strategies for clinicians caring for critically ill children aimed to maintain a physiologically relevant hemoglobin concentration, optimize hemostasis and minimize blood loss in an effort to improve patient outcomes. There remains a paucity of research in this area for children so a research guide is desperately needed. The Pediatric Critical Care Transfusion and Anemia Expertise Initiative (TAXI), in collaboration with the Pediatric Critical Care Blood Research Network (BloodNet), the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI), the American Association of Blood Banks (AABB) and the Society for Critical Care Medicine (SCCM), proposes a conference series led by international and multidisciplinary experts to develop pediatric critical care blood management consensus for clinical guidance and future research efforts. This group will create a comprehensive series of consensus statements via an organized and structured process over 2 years to outline existing data and future research foci in the area of pRBC transfusions in critically ill children. TAXI has obtained letters of agreement/support from over 40 international experts for this project, as well as from the SCCM and the AABB, who are actively engaged and positioned to endorse the consensus products. Novel features of this initiative include early engagement with formal implementation science, medical anthropology and human factor engineering experts, so that we may best guide consensus statement uptake in order to improve outcomes and safety for children at risk for, or who require, pRBC transfusion. The consensus statements will include specific strategies for adaptive dissemination and implementation into various clinical/research environments. It will also be imperative that the statements be developed with an approach that accounts for the challenges in the environment and overall medical culture that may limit wide application and dissemination of the statement's recommendations.
描述(由申请人提供):近一半的危重儿童与儿科重症监护病房(PICU)的住院期和48小时将接受输注红细胞(PRBC)。尽管有证据表明,在PICU中输入较低的pRBC血红蛋白门槛是安全的,但多项研究表明,实际应用中的门槛要高得多,使儿童面临与pRBC相关的显著发病率和死亡率。因此,对于护理危重儿童的临床医生来说,越来越需要循证的血液管理策略,旨在保持生理上相关的血红蛋白浓度,优化止血,并尽量减少失血,以努力改善患者的预后。在这一领域针对儿童的研究仍然很少,因此迫切需要一份研究指南。儿科重症监护输血和贫血专业知识倡议(TAIL)与儿科重症监护血液研究网络(BroudNet)、儿科急性肺损伤和败血症调查员(PALISI)、美国血库协会(AABB)和重症监护医学会(SCCM)合作,提议由国际和多学科专家领导的一系列会议,为临床指导和未来研究工作制定儿科重症监护血液管理共识。该小组将在两年内通过有组织和结构化的过程创建一系列全面的共识声明,概述危重儿童pRBC输注领域的现有数据和未来的研究重点。出租车已经获得了40多名国际专家对该项目的同意/支持,以及SCCM和AABB的支持,他们积极参与并处于支持共识产品的地位。这一倡议的新特点包括及早与正式的实施科学、医学人类学和人类因素工程专家接触,以便我们可以最好地指导共识声明的理解,以便改善接受pRBC输血的风险儿童或需要pRBC输血的儿童的结局和安全性。共识声明将包括在各种临床/研究环境中进行适应性传播和实施的具体战略。还必须考虑到环境和整体医学文化中可能限制广泛应用和传播声明建议的挑战。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Scot Thomas Bateman其他文献
Scot Thomas Bateman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
- 批准号:
10719249 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
- 批准号:
23K07651 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
- 批准号:
10679944 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
- 批准号:
10575258 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
Roles of N-glycans on neutrophil beta2 integrins in progression of acute lung injury
N-聚糖对中性粒细胞β2整合素在急性肺损伤进展中的作用
- 批准号:
10837431 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别: